Medical Devices Startups

UV Medico develops Far-UVC light technology (UV222) designed to disinfect surfaces and environments by neutralizing viruses, bacteria, mold, and antibiotic-resistant microorganisms. The company serves healthcare facilities and public spaces seeking safe, human-compatible disinfection solutions.

1 investor

V-Flow Medical develops medical devices intended to address the underlying causes of chronic pelvic pain in women, aiming to reduce opioid dependence and improve patient quality of life.

1 investor

Vaccine Systems develops SureVax, an automated vaccine reconstitution and preparation system with temperature monitoring and data tracking, aimed at reducing waste and error in mixing modified live virus and freeze-dried vaccines. It serves both livestock producers and human healthcare caregivers running vaccination campaigns.

1 investor

Vactech develops preventive vaccines and diagnostic technologies for type 1 diabetes, celiac disease, and enterovirus-related conditions. The company combines academic research with clinical development, advancing a patented preventive vaccine for type 1 diabetes through clinical trials with projected commercial impact in the US and EU.

1 investor

Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage. The company serves healthcare providers with medical technology aimed at earlier sepsis diagnosis.

1 investor

Valcare Medical develops transcatheter solutions for treating mitral regurgitation, a structural heart condition, aiming to provide surgical-level durability without open-heart surgery. The company's flagship system is designed for interventional cardiologists and patients requiring mitral valve repair.

1 investor

Valencia Technologies is a neuromodulation company that makes eCoin, an FDA-approved coin-sized tibial nerve implant for treating Urge Urinary Incontinence. The leadless neurostimulator is placed under the skin near the ankle in a minimally invasive procedure to provide drug-free bladder control therapy for patients.

1 investor

VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure. The technology targets patients with mitral valve disease and heart failure.

1 investor

Validproof provides a traceability and compliance platform for pharmaceutical companies to verify product origin, authenticity, and delivery status throughout the supply chain and prevent counterfeiting.

1 investor

Valius is a molecular oncology company that develops tools to understand cancer cell behavior and enable targeted drug development and personalized therapies. It serves clinical and pharmaceutical organizations focused on improving cancer treatment outcomes.

1 investor

Valkyrie Industries develops EMS wearable bands (eir) that integrate with VR and mobile apps to support neuromuscular recovery in clinical and fitness settings. The technology enables real-time muscle activation feedback for functional therapy, rehabilitation, and performance training.

1 investor

ValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.

1 investor

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics. The company's management team specializes in mitochondrial function and neurological disease treatment.

1 investor

Vantage Biosciences develops clinical-stage drug therapies for retinal and other diseases, with a focus on the AOC3 target and its role in liver and eye disease. The company works with a network of preclinical and clinical experts to advance therapeutics where existing treatment options are limited.

1 investor

Vantari provides VR-based procedural training for healthcare professionals, combining immersive simulation with AI-powered performance analytics and a community platform for medical education.

1 investor

Siemens Healthineers provides integrated technology solutions for cancer care, spanning screening, diagnosis, treatment planning, delivery, and survivorship support. The portfolio aims to coordinate fragmented workflows and simplify clinical decision-making across the cancer care continuum.

1 investor

VascuBio Innovation develops microfluidics, biomaterials, and biofabrication platforms—including bioreactors, screening systems, and organ-on-chip technologies—for drug screening, tissue engineering, and regenerative medicine. Founded on academic research connected to McGill University, it serves researchers and industry seeking human-relevant in vitro models that reduce reliance on animal testing.

1 investor

Vascugen develops an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell therapy intended to form new blood vessels and restore microvascular circulation in oxygen-starved tissues. It targets diabetic and arterial disease patients at high risk of limb amputation, and handles development from R&D through cGMP manufacturing.

1 investor

Vasomune is a clinical-stage biotech company developing therapeutic treatments for vascular and immune-related diseases. The company focuses on bringing drug candidates like AV-001 from laboratory research to clinical applications for patients with serious conditions.

1 investor

Vave Health develops portable, affordable ultrasound imaging technology aimed at clinicians and healthcare providers, including those serving underserved areas. Its products are used in settings such as medical schools for integrating ultrasound into training.

1 investor

VB Spine develops spinal surgery systems, instrumentation, and surgeon education programs, serving spine surgeons and their patients. It operates in the medical device industry with a product portfolio and clinical resources focused on spine surgery.

1 investor

VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.

1 investor

Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies. The company focuses on the neurological and pharmaceutical sectors to serve the global migraine patient population.

1 investor

Beidenmedical is a medical device supplier and distributor serving healthcare dealers and partners in China, operating a digital supply and services platform for medical equipment distribution.

1 investor